Biogen beats quarterly profit estimates on strong demand for rare disease drugs

• click to rate

  Posted by Two Blokes May 1 - Filed in Stock - 0 views
  
  Biogen beat first-quarter profit and revenue expectations on Thursday, as strong demand for its rare disease drugs helped offset declining sales of its multiple sclerosis drugs.